Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Lower LDL-c levels predict higher COVID-19 mortality.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Human hair protein modifications could potentially indicate heart disease risk.

Liver transplantation is a viable option for children with propionic acidemia, improving quality of life and diet, but does not remove all risks and long-term brain outcomes are uncertain.

The document concludes that the exact way alcohol causes harm to fetal development is unknown, but it significantly affects nutrient transport to the fetus and a safe level of alcohol during pregnancy is not determined.

The conclusion is that recognizing hair growth cycles can improve the precision of dietary and health assessments from hair analysis.

Certain micronutrients may improve hair and nail health, but more research is needed to confirm their benefits.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Low iron levels may be linked to some types of hair loss in women.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Low iron levels are not directly linked to chronic hair loss and iron supplements may not help.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

A new gene, JMJD1C, may affect testosterone levels in men.

Testosterone with or without finasteride doesn't improve thinking skills in older men with low testosterone.

People with hair loss, especially those with certain types, have lower zinc levels, and zinc supplements might help.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Biotin deficiency is not a major cause of hair loss in women, so biotin supplements are not likely to be an effective hair loss treatment.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Zinc supplements increased zinc levels in some hair loss patients but didn't significantly improve hair growth.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Low iron and vitamin D levels are linked to hair loss in women.

Higher iron levels in the blood are not linked to increased hair loss in women.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

The 0.25% finasteride solution, when applied once a day, effectively reduces scalp DHT, potentially minimizing sexual side-effects linked to a systemic DHT reduction.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.